Iron and iron chelating agents modulate Mycobacterium tuberculosis growth and monocyte-macrophage viability and effector functions
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Excess of iron promotes Mycobacterium tuberculosis infection, its replication and progression to clinical disease and death from tuberculosis. Chelation of iron may reduce M. tuberculosis replication, restore host defence mechanisms and it could constitute an application in the prevention and treatment strategies where both iron overload and tuberculosis are prevalent. We investigated the effect of iron and iron chelating agents, like desferrioxamine and silybin, individually and in combination with iron on mycobacterial number, viability in culture and after recovery from monocyte-macrophages, together with monocyte-macrophages viability and oxidative defence. Mycobacterial number and viability in culture were assessed using real-time quantitative PCR of H37Rv IS6110 DNA, 16S rRNA and 85B mRNA, whereas the microplate AlamarBlue(TM) assay was used to detect viability in culture post-infection. Mitochondrial membrane potential and phosphatidyl serine exposure of monocyte-macrophages, detected using Mitotracker Red fluorescence and Annexin V binding, respectively, served as indicators of host cell viability. Superoxide generation served as marker of monocyte-macrophage effector functions. Extracellular H37Rv showed a significant increase in number and viability in presence of excess iron and, by large, a significant decrease in number and viability in presence of the iron chelating agents, silybin and desferrioxamine, compared to cultivation without supplementation. Intracellularly, excess iron increased H37Rv viability significantly but reduced monocyte-macrophages mitochondrial membrane potential and compromised superoxide production. Desferrioxamine had little influence on intracellular parameters, but consistently prevented effects of excess iron, while silybin significantly altered most intracellular parameters and mostly failed to prevent effects of excess iron. These findings suggest that chelation therapy should be considered in conditions of iron overload and that effective chelating agents like desferrioxamine, with limited intracellular access might need to be used in combination with lypophilic chelating agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schaible, U. E., Collins, H. L., Priem, F., & Kaufmann, S. H. E. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020897 · Cited by 198
Gordeuk, V. R., Caleffi, A., Corradini, E., Ferrara, F., Jones, R. A., Castro, O., Onyekwere, O., Kittles, R., Pignatti, E., Montosi, G., et al. (2003) · Blood Cells, Molecules, and Diseases · doi:10.1016/s1079-9796(03)00164-5 · Cited by 198
Association of Pulmonary Tuberculosis with Increased Dietary Iron
Gangaidzo, I. T., Moyo, V. M., Mvundura, E., Aggrey, G., Murphree, N. L., Khumalo, H., Saungweme, T., Kasvosve, I., Gomo, Z. A. R., Rouault, T., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/323203 · Cited by 191
Mechanisms of iron regulation in mycobacteria: role in physiology and virulence
Rodriguez, G. M., & Smith, I. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03384.x · Cited by 162
Role of Iron in Nramp1-Mediated Inhibition of Mycobacterial Growth
Zwilling, B. S., Kuhn, D. E., Wikoff, L., Brown, D., & Lafuse, W. (1999) · Infection and Immunity · doi:10.1128/iai.67.3.1386-1392.1999 · Cited by 155
Gordeuk, V., McLaren, C., MacPhail, A., Deichsel, G., & Bothwell, T. (1996) · Blood · doi:10.1182/blood.v87.8.3470.bloodjournal8783470 · Cited by 154
Iron and Mycobacterium tuberculosis infection
Lounis, N., Truffot-Pernot, C., Grosset, J., Gordeuk, V. R., & Boelaert, J. R. (2001) · Journal of Clinical Virology · doi:10.1016/s1386-6532(00)00136-0 · Cited by 142
Caviedes, L., Delgado, J., & Gilman, R. H. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.5.1873-1874.2002 · Cited by 119
Kuhn, D. E., Baker, B. D., Lafuse, W. P., & Zwilling, B. S. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.1.113 · Cited by 113
Iron Chelation Therapy for Malaria
Mabeza, G. F., Loyevsky, M., Gordeuk, V. R., & Weiss, G. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00037-0 · Cited by 111
The role of iron in infections with intracellular bacteria
Collins, H. L. (2003) · Immunology Letters · doi:10.1016/s0165-2478(02)00229-8 · Cited by 94
Cited by
Manganese: Recent advances in understanding its transport and neurotoxicity
Aschner, M., Guilarte, T. R., Schneider, J. S., & Zheng, W. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.03.001 · Cited by 626
Iron supplementation in early childhood: health benefits and risks
Iannotti, L. L., Tielsch, J. M., Black, M. M., & Black, R. E. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.6.1261 · Cited by 321
Iron metabolism and the innate immune response to infection
Johnson, E. E., & Wessling-Resnick, M. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2011.10.001 · Cited by 253
“Both in vitro and in vivo models consistently have demonstrated that the addition of exogenous iron enhances mycobacterial growth [57-60].”
BackgroundThe Effect of the Host’s Iron Status on Tuberculosis
Boelaert, J. R., Vandecasteele, S. J., Appelberg, R., & Gordeuk, V. R. (2007) · The Journal of Infectious Diseases · doi:10.1086/518040 · Cited by 217
Olakanmi, O., Schlesinger, L. S., & Britigan, B. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0606405 · Cited by 88
Metadata
- Authors
- Cronjé, L., Edmondson, N., Eisenach, K. D., & Bornman, L.
- Venue
- FEMS Immunology & Medical Microbiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-08
- Volume
- 45
- Issue
- 2
- Pages
- 103-112
- ISSN
- 0928-8244 (ISSN-L)
- 1574-695X
- OpenAlex
- W1969702453
- Cited by
- 72
- References
- 11
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.